Loading
PP
PT Phapros Tbk Stock: price and insider trades · Indonesia
No insider purchase over the last 90 days. The latest, by Masrizal A. Syarief, was filed 23 Jul 2024.
PT Phapros Tbk: what insiders have been doing
PT Phapros Tbk is a Health Care company based in Jakarta, Indonesia. Its directors and officers file their transactions with OJK / IDX. No insider at PT Phapros Tbk has published a filing in the past twelve months. The most recent one dates from 23 July 2024.
Over the whole record (from 2023), the tally stands at 37 purchases and 2 sales.
For comparison within the same sector, see the insider buying recorded at Dynavox Group AB and EssilorLuxottica. Every figure here comes from the filings published by OJK / IDX and describes the past, not future prices; it is not investment advice.
Key facts
Headquarters: Jakarta, Indonesia
Source: Wikidata (CC0).
Insider Decl.
39
Thresholds
n/a
Buy Volume
€35,949
37 ops. · all time
Sell Volume
€51,783
2 ops. · all time
Since the insiders bought
- -9.7%Entry IDR 350.00 · Close at T+365 IDR 316.00
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 5,189 of 26,250 companies
67.1
score / 100
Value87
Quality48
FCF yld60%
Earn yld14%
EV/EBITDA8.2x
ROE9.6%
Gross mgn52%
Net mgn3.0%
Debt/EBITDA6.4x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
IDR 232.00
Analyst consensus
Income statement
RevenueIDR 940.9B
Gross profitIDR 492.5B52% margin
EBITDAIDR 109.6B12% margin
Net incomeIDR 28B4.2% margin
Valuation
PER (trailing)5.2x
P/Book0.5x
Beta0.40
Balance sheet & cash
Market capIDR 194.9B
Total debtIDR 706.7B
Free Cash FlowIDR 116.7B
Debt / Equity162%
Profitability & ownership
ROE9.6%
ROA5.4%
% insiders73.2%
% institutions0.0%
Last declaration on 23 July 2024
Declarations39 total
21,200 shares@ IDR 344.000.5% of flowIDXIDX:21-S.KOM-MAS-PH-VII-2024-PEHA#0
Canonical exit: 20 Oct 2024 (T+90)
30,000 shares@ IDR 346.000.7% of flowIDXIDX:20-S.KOM-MAS-PH-VII-2024-PEHA#0
Canonical exit: 14 Oct 2024 (T+90)
15,000 shares@ IDR 322.000.3% of flowIDXIDX:20-S.KOM-MAS-PH-VI-2024-PEHA#0
Canonical exit: 26 Sept 2024 (T+90)
15,000 shares@ IDR 482.000.5% of flowIDXIDX:15-S.KOM-MAS-PH-V-2024-PEHA#0
Canonical exit: 15 Aug 2024 (T+90)
15,000 shares@ IDR 484.000.5% of flowIDXIDX:15-S.KOM-MAS-PH-V-2024-PEHA#1
Canonical exit: 15 Aug 2024 (T+90)
4,400 shares@ IDR 484.000.1% of flowIDXIDX:14-S.KOM-MAS-PH-V-2024-PEHA#0
Canonical exit: 13 Aug 2024 (T+90)
15,000 shares@ IDR 486.000.5% of flowIDXIDX:14-S.KOM-MAS-PH-V-2024-PEHA#1
Canonical exit: 13 Aug 2024 (T+90)
25,000 shares@ IDR 490.000.8% of flowIDXIDX:13-S.KOM-MAS-PH-V-2024-PEHA#0
Canonical exit: 29 Jul 2024 (T+90)
25,000 shares@ IDR 492.000.8% of flowIDXIDX:13-S.KOM-MAS-PH-V-2024-PEHA#1
Canonical exit: 29 Jul 2024 (T+90)
13,500 shares@ IDR 515.000.5% of flowIDXIDX:09-S.KOM-MAS-PH-III-2024-PEHA#0
Canonical exit: 16 Jun 2024 (T+90)
13,200 shares@ IDR 515.000.5% of flowIDXIDX:09-S.KOM-MAS-PH-III-2024-PEHA#1
Canonical exit: 17 Jun 2024 (T+90)
50,000 shares@ IDR 515.001.7% of flowIDXIDX:09-S.KOM-MAS-PH-III-2024-PEHA#2
Canonical exit: 18 Jun 2024 (T+90)
36,000 shares@ IDR 555.001.4% of flowIDXIDX:01-S.KOM-MAS-PH-I-2024-PEHA#0
Canonical exit: 21 Apr 2024 (T+90)
36,000 shares@ IDR 555.001.4% of flowIDXIDX:01-S.KOM-MAS-PH-I-2024-PEHA#1
Canonical exit: 23 Apr 2024 (T+90)
36,000 shares@ IDR 555.001.3% of flowIDXIDX:01-S.KOM-MAS-PH-I-2024-PEHA#2
Canonical exit: 24 Apr 2024 (T+90)
46,500 shares@ IDR 535.001.7% of flowIDXIDX:01-S.KOM-MAS-PH-I-2024-PEHA#3
Canonical exit: 25 Apr 2024 (T+90)
500,000 shares@ IDR 976.6833.2% of flowIDXIDX:36-S.KOM-MAS-PH-XII-2023-PEHA#0
500,000 shares@ IDR 754.0525.8% of flowIDXIDX:35-S.KOM-MAS-PH-XII-2023-PEHA#0
10,000 shares@ IDR 545.000.4% of flowIDXIDX:34-S.KOM-MAS-PH-XII-2023-PEHA#0
Canonical exit: 22 Feb 2024 (T+90)
31,500 shares@ IDR 545.001.2% of flowIDXIDX:34-S.KOM-MAS-PH-XII-2023-PEHA#1
Canonical exit: 7 Mar 2024 (T+90)
32,200 shares@ IDR 620.001.4% of flowIDXIDX:31-S.KOM-MAS-PH-X-2023-PEHA#0
Canonical exit: 17 Jan 2024 (T+90)
2,100 shares@ IDR 625.000.1% of flowIDXIDX:30-S.KOM-MAS-PH-X-2023-PEHA#1
Canonical exit: 15 Jan 2024 (T+90)
6,300 shares@ IDR 625.000.3% of flowIDXIDX:30-S.KOM-MAS-PH-X-2023-PEHA#0
Canonical exit: 14 Jan 2024 (T+90)
39,600 shares@ IDR 630.001.7% of flowIDXIDX:29-S.KOM-MAS-PH-X-2023-PEHA#0
Canonical exit: 10 Jan 2024 (T+90)
39,300 shares@ IDR 635.001.7% of flowIDXIDX:28-S.KOM-MAS-PH-X-2023-PEHA#0
Canonical exit: 8 Jan 2024 (T+90)
25 of 39 declarations
About PT Phapros Tbk
PT Phapros Tbk is an Indonesian pharmaceutical company that specializes in the production of medicines and health products. It is listed on the Indonesia Stock Exchange (XIDX).
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations